ES8802206A1 - Procedimiento para la preparacion de microparticulas que permiten la liberacion prolongada de una substancia biologicameente activa. - Google Patents
Procedimiento para la preparacion de microparticulas que permiten la liberacion prolongada de una substancia biologicameente activa.Info
- Publication number
- ES8802206A1 ES8802206A1 ES554821A ES554821A ES8802206A1 ES 8802206 A1 ES8802206 A1 ES 8802206A1 ES 554821 A ES554821 A ES 554821A ES 554821 A ES554821 A ES 554821A ES 8802206 A1 ES8802206 A1 ES 8802206A1
- Authority
- ES
- Spain
- Prior art keywords
- microparticles
- biologically active
- extrusion
- preparation
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Peptides Or Proteins (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE MICROCAPSULAS QUE PERMITEN LA LIBERACION PROLONGADA DE UNA SUSTANCIA BIOLOGICAMENTE ACTIVA EN EL QUE SE PREPARA UN GRANULADO HOMOGENEO CONSTITUIDO POR 5 A 40% EN PESO DE CETOPROFENO COMO SUSTANCIA ACTIVA, UNO O VARIOS POLIMEROS COMPATIBLES Y DE 10 A 40% EN PESO DE LA COMPOSICION DE UNA MEZCLA DE AL MENOS DOS EXCIPIENTES LIPIDICOS UNO DE LOS CUALES POSEE LA PROPIEDAD DE DISOLVER O DE GELIFICAR EL O LOS POLIMEROS Y EL OTRO POSEE PROPIEDADES LUBRIFICANTES O DE UN EXCIPIENTE LIPIDICO QUE POSEA A LA VEZ LA PROPIEDAD DE DISOLVER O DE GELIFICAR EL O LOS POLIMEROS Y PROPIEDADES LUBRIFICANTES Y EVENTUALMENTE UNO O VARIOS ADITIVOS ELEGIDOS DE ENTRE LOS DILUYENTES Y LOS AGENTES ANTIESTATICOS. EL GRANULADO SE EXTRUYE A TEMPERATURA TAL QUE EL EXCIPIENTE LIPIDICO ESTE FUNDIDO PARCIALMENTE PARA DAR UNA MASA PLASTICA QUE SE RESOLIDIFIQUE DESPUES DE LA EXTRUSION. TIENE APLICACION EN LA INDUSTRIA FARMACEUTICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8507013A FR2581541B1 (fr) | 1985-05-09 | 1985-05-09 | Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8802206A1 true ES8802206A1 (es) | 1988-04-16 |
ES554821A0 ES554821A0 (es) | 1988-04-16 |
Family
ID=9319093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES554821A Expired ES8802206A1 (es) | 1985-05-09 | 1986-05-09 | Procedimiento para la preparacion de microparticulas que permiten la liberacion prolongada de una substancia biologicameente activa. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0204596B1 (es) |
JP (1) | JPS61260029A (es) |
KR (1) | KR860008774A (es) |
AT (1) | ATE45283T1 (es) |
AU (1) | AU579012B2 (es) |
CA (1) | CA1266841A (es) |
DE (1) | DE3664867D1 (es) |
DK (1) | DK217286A (es) |
ES (1) | ES8802206A1 (es) |
FI (1) | FI861923A (es) |
FR (1) | FR2581541B1 (es) |
MA (1) | MA20670A1 (es) |
NZ (1) | NZ216082A (es) |
ZA (1) | ZA863431B (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2061394A1 (es) * | 1993-02-05 | 1994-12-01 | Robert S A Lab | Procedimiento de fabricacion de un granulado de citrato potasico con cesion retardada. |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL81419A0 (en) * | 1986-01-30 | 1987-08-31 | Syntex Inc | Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation |
US5198226A (en) * | 1986-01-30 | 1993-03-30 | Syntex (U.S.A.) Inc. | Long acting nicardipine hydrochloride formulation |
US4940556A (en) * | 1986-01-30 | 1990-07-10 | Syntex (U.S.A.) Inc. | Method of preparing long acting formulation |
SE457326B (sv) * | 1986-02-14 | 1988-12-19 | Lejus Medical Ab | Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa |
DE3612212A1 (de) * | 1986-04-11 | 1987-10-15 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen formen |
NL8701335A (nl) * | 1986-06-21 | 1988-01-18 | Sandoz Ag | Orale farmaceutische preparaten. |
FR2634376B1 (fr) | 1988-07-21 | 1992-04-17 | Farmalyoc | Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation |
FR2663818B1 (fr) * | 1990-06-29 | 1993-07-09 | Rhone Poulenc Nutrition Animale | Procede de preparation de granules de principes actifs par extrusion. |
DE4021678C2 (de) * | 1990-07-07 | 1994-07-07 | Merz & Co Gmbh & Co | Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen |
DE4031881C2 (de) * | 1990-10-08 | 1994-02-24 | Sanol Arznei Schwarz Gmbh | Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung |
WO1993007859A1 (en) * | 1991-10-23 | 1993-04-29 | Warner-Lambert Company | Novel pharmaceutical pellets and process for their production |
ES2086229T3 (es) * | 1992-05-22 | 1996-06-16 | Goedecke Ag | Procedimiento para la obtencion de preparados medicinales de accion retardada. |
US5700410A (en) * | 1992-10-16 | 1997-12-23 | Nippon Shinyaku Co., Ltd. | Method of manufacturing wax matrices |
US5843347A (en) * | 1993-03-23 | 1998-12-01 | Laboratoire L. Lafon | Extrusion and freeze-drying method for preparing particles containing an active ingredient |
FR2702968B1 (fr) * | 1993-03-23 | 1995-06-23 | Lafon Labor | Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation . |
BE1006990A5 (nl) * | 1993-04-22 | 1995-02-07 | Univ Gent | Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen. |
FR2710500B1 (fr) * | 1993-09-27 | 1995-12-01 | Virbac Laboratoires | Composition et système à administration orale pour animaux, leur procédé de préparation et leurs applications. |
DE4422881A1 (de) * | 1993-10-25 | 1995-04-27 | Bayer Ag | Kolloidal dispergierbare Wirkstoff-Formulierungen |
PT744941E (pt) * | 1994-02-16 | 2003-10-31 | Abbott Lab | Processo para preparar formulacoes farmaceuticas de particulas finas |
DE4413350A1 (de) * | 1994-04-18 | 1995-10-19 | Basf Ag | Retard-Matrixpellets und Verfahren zu ihrer Herstellung |
GB9422154D0 (en) * | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
DE29502547U1 (de) * | 1995-02-16 | 1995-03-30 | Röhm GmbH, 64293 Darmstadt | Thermoplastisches Überzugs- und Bindemittel für Arzneiformen |
DE19531277A1 (de) * | 1995-08-25 | 1997-02-27 | Basf Ag | Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren |
DE19539363A1 (de) * | 1995-10-23 | 1997-04-24 | Basf Ag | Verfahren zur Herstellung von festen Arzneiformen |
GB2344520A (en) * | 1998-12-08 | 2000-06-14 | Phares Pharm Res Nv | Pharmaceutical carriers comprising lipids and polymers |
DE10029201A1 (de) | 2000-06-19 | 2001-12-20 | Basf Ag | Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung |
US6733709B2 (en) | 2000-08-03 | 2004-05-11 | The Procter & Gamble Company | Methods and apparatus for producing granular compositions |
WO2018140941A1 (en) * | 2017-01-30 | 2018-08-02 | Case Western Reserve University | Polymer constructs for controlled release of guest agents |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3146167A (en) * | 1961-10-05 | 1964-08-25 | Smith Kline French Lab | Method of preparing sustained release pellets and products thereof |
US3247065A (en) * | 1963-10-14 | 1966-04-19 | Hoffmann La Roche | Free-flowing coated ascorbic acid |
US3965256A (en) * | 1972-05-16 | 1976-06-22 | Synergistics | Slow release pharmaceutical compositions |
DE3024416C2 (de) * | 1980-06-28 | 1982-04-15 | Gödecke AG, 1000 Berlin | Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung |
FR2515035A1 (fr) * | 1981-10-26 | 1983-04-29 | Rhone Poulenc Sante | Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication |
IT1200217B (it) * | 1986-09-30 | 1989-01-05 | Valducci Roberto | Membrana per uso farmaceutico ed industriale |
-
1985
- 1985-05-09 FR FR8507013A patent/FR2581541B1/fr not_active Expired
-
1986
- 1986-04-30 MA MA20895A patent/MA20670A1/fr unknown
- 1986-05-07 AU AU57224/86A patent/AU579012B2/en not_active Ceased
- 1986-05-07 ZA ZA863431A patent/ZA863431B/xx unknown
- 1986-05-07 NZ NZ216082A patent/NZ216082A/xx unknown
- 1986-05-08 KR KR1019860003576A patent/KR860008774A/ko not_active Application Discontinuation
- 1986-05-08 JP JP61103953A patent/JPS61260029A/ja active Pending
- 1986-05-08 CA CA000508680A patent/CA1266841A/fr not_active Expired - Lifetime
- 1986-05-08 FI FI861923A patent/FI861923A/fi not_active Application Discontinuation
- 1986-05-09 DK DK217286A patent/DK217286A/da not_active Application Discontinuation
- 1986-05-09 DE DE8686400996T patent/DE3664867D1/de not_active Expired
- 1986-05-09 AT AT86400996T patent/ATE45283T1/de not_active IP Right Cessation
- 1986-05-09 EP EP86400996A patent/EP0204596B1/fr not_active Expired
- 1986-05-09 ES ES554821A patent/ES8802206A1/es not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2061394A1 (es) * | 1993-02-05 | 1994-12-01 | Robert S A Lab | Procedimiento de fabricacion de un granulado de citrato potasico con cesion retardada. |
Also Published As
Publication number | Publication date |
---|---|
EP0204596A1 (fr) | 1986-12-10 |
ATE45283T1 (de) | 1989-08-15 |
AU5722486A (en) | 1986-11-13 |
AU579012B2 (en) | 1988-11-10 |
FI861923A (fi) | 1986-11-10 |
CA1266841A (fr) | 1990-03-20 |
FR2581541A1 (fr) | 1986-11-14 |
ZA863431B (en) | 1986-12-30 |
FI861923A0 (fi) | 1986-05-08 |
JPS61260029A (ja) | 1986-11-18 |
DE3664867D1 (en) | 1989-09-14 |
ES554821A0 (es) | 1988-04-16 |
DK217286A (da) | 1986-11-10 |
DK217286D0 (da) | 1986-05-09 |
NZ216082A (en) | 1989-01-06 |
KR860008774A (ko) | 1986-12-18 |
MA20670A1 (fr) | 1986-12-31 |
EP0204596B1 (fr) | 1989-08-09 |
FR2581541B1 (fr) | 1988-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8802206A1 (es) | Procedimiento para la preparacion de microparticulas que permiten la liberacion prolongada de una substancia biologicameente activa. | |
DK0544144T3 (da) | Fast farmaceutisk retardform | |
ES8500740A1 (es) | Un metodo para la preparacion de una forma posologica unitaria solida, terapeuticamente activa, con pauta de liberacion regular y prolongada al ser administrada. | |
TR199700786T1 (xx) | Kat� aktif madde bile�imleri. | |
EP0232877A3 (en) | Buccal drug dosage form | |
BR9910574A (pt) | Compostos tendo derivado de ácido glicurÈnico e derivado de glicosamina em sua estrutura, método para a produção dos compostos, e uso dos compostos | |
FR2545354B1 (fr) | Composition pharmaceutique pour l'administration parenterale a base de nimodipin et procede pour sa preparation | |
ATE13545T1 (de) | Stabilisatorzusammensetzungen, halogenhaltige polymerzusammensetzungen, welche diese enthalten, und geformte gegenstaende, welche die polymerzusammensetzungen enthalten. | |
IT8919193A0 (it) | Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono. | |
PT89055A (pt) | Processo para a preparacao de um sistema de administracao de libertacao sustida para bloqueadores de canal de calcio a base de di-hidropiridinas substituidas | |
EP0253143A3 (en) | Pharmaceutical compositions for suppository | |
ES8503949A1 (es) | "metodo de preparacion de una composicion contraceptiva para administracion vaginal" | |
AU566228B2 (en) | Compressed hydroxybutryic acid polymer retarded release vehicle | |
CA2028222A1 (en) | Polymeric additives | |
BE902796A (fr) | Ester d'acetyl carnitine, sa preparation et son utilisation. | |
EP0481240A3 (en) | Galactomannan derivate for the encapsulation or incorporation of drugs | |
GB8603964D0 (en) | Compositions | |
EP0380989A3 (en) | Plaster for transdermal administration | |
EP0268927A3 (en) | Resin-coated, non-sorptive granular, pesticidal compositions and method for the preparation thereof | |
IE873162L (en) | Pesticidal compositions | |
IL93721A0 (en) | Mixed micelles compositions and their use as carriers for the parenteral application of the drugs | |
ES2079745T3 (es) | Polimeros de estireno expandibles con un primer recubrimiento, que contiene bisamidas. | |
CO4180439A1 (es) | Composiciones que comprenden polimeros de polialquilenamina etoxilados/propoxilados como agentes de separacion de sucio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed |
Effective date: 19960506 |